Douglas E. Brough

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial”.

PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00368-0

N/A

0.935DataRank · unranked

23 citations

Janet Valdez, Scott Napier, Meg Kenyon, Erin Ferraro, Melissa Wheatley +9 more

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

npj Vaccines(2021)10.1038/s41541-021-00348-x

N/A

0DataRank · unranked

12 citations

Simon Metenou, Douglas E. Brough, Helen Sabzevari, Ke Bai, Caroline Jochéms +3 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009

JCI Insight(2021)10.1172/jci.insight.141912

N/A

0DataRank · unranked

24 citations

Claire Smalley, Y. Maurice Morillon, Nicholas Roller, Lisa K. Poppe, Douglas E. Brough +4 more

The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis

Science Translational Medicine(2023)10.1126/scitranslmed.adj0740

N/A

0DataRank · unranked

26 citations

Ke Bai, Cem Sievers, Yvette Robbins, Jay Friedman, Xinping Yang +10 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more